BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Welichem Biotech Inc. 

316-4475 Wayburne Drive

Burnaby  British Columbia  V5G 3L1  Canada
Phone: 604-432-1703 Fax: 604-432-1704


SEARCH JOBS




Industry
Biotechnology






 Company News
Welichem Biotech Inc. (WBI.V) Responds To Filing Of Take-Over Bid Circular 4/17/2014 12:21:30 PM
Welichem Biotech Inc. (WBI.V) Announces Substantial Issuer Bid 10/10/2013 9:33:27 AM
Welichem Biotech Inc. (WBI.V) Announces Substantial Issuer Bid 9/3/2013 7:35:05 AM
Welichem Biotech Inc. (WBI.V) Enters $9.8 Million Pact in China, Taiwan, Macao and Hong Kong 3/29/2013 7:04:09 AM
GlaxoSmithKline (GSK)'s Stiefel Laboratories Pays Welichem Biotech Inc. (WBI.V) $50 Million for Topical Agent for Psoriasis, Atopic Dermatitis 5/31/2012 7:29:41 AM
Welichem Biotech Inc. (WBI.V) Announces IND-Enabling Toxicology Studies for its Lead Drug, WBI-1001 4/20/2009 11:30:08 AM
Welichem Biotech Inc. (WBI.V) Announces Appointment of President & CEO 6/30/2008 7:08:58 AM
Welichem Biotech Inc. (WBI.V) Completes Phase IIa Clinical Trial on Eczema 6/20/2008 12:20:11 PM
Welichem Biotech Inc. (WBI.V) Successfully Moves to Higher Dose for Phase I Clinical Trials 9/10/2007 3:03:38 PM
Welichem Biotech Inc. (WBI.V) Announces Investor Relations Appointment 10/24/2006 4:35:57 PM